Danish biotech Adcendo has accelerated its progression to a clinical-stage biotech by licensing an antibody-drug conjugate (ADC) from China's Multitude Therapeutics with potential in various forms of ...
8.2.1. COâ‚‚ utilization forecast by category (million metric tonnes of COâ‚‚ per year), 2024-2044 8.2.2. COâ‚‚ utilization forecast by product (million metric tonnes of COâ‚‚ per year), 2024-2044 8.2.3. Data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results